Fact Sheet — Harnessing American AI to Unlock Cures for Pediatric Cancer
Update: 2025-10-01
Description
Fact Sheet — Harnessing American AI to Unlock Cures for Pediatric Cancer
Key Actions:
- MAHA Commission directed to:
- HHS to:
- Funding and Partnerships:
Why it matters:
- Pediatric cancer is the leading cause of disease-related death for U.S. children; incidence has risen over 40% since 1975.
- AI can turn multi-omics and imaging data into new diagnostic, prognostic, and therapeutic biomarkers; improve predictive modeling; and enhance trial design, access, and outcomes.
Context and prior steps:
- CCDI launched in 2019 to build a foundational national data infrastructure.
- Childhood Cancer STAR Act signed to bolster research, surveillance, and survivor support.
- 2025 actions include: creating the MAHA Commission; releasing the Make Our Children Healthy Again Assessment; revitalizing the President’s Council on Sports, Fitness, and Nutrition (and the Presidential Fitness Test); publishing America’s AI Action Plan; and issuing the Make Our Children Healthy Again Strategy (120+ initiatives).
Takeaway:
This EO aligns federal policy, data infrastructure, and standards to accelerate AI-powered pediatric cancer research and care, aiming for faster diagnostics, better treatments, and improved outcomes while safeguarding patient privacy.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
